C2GA provides the breakthrough technology of Genetic Algorithms to evolve a family of predictive models for use in Cerius2. C2
GA is used to develop QSAR models from receptor surface and other data, and is also useful in variable selection for field-based 3D QSAR.
Jo Ellen Collins
Dir., Inside Sales/Mar Com
BIOSYM Technologies Inc
16 New England Executive Park
Burlington, MA 01803
USA
617-229-9800
617-229-9899 (fax)
jcollins@msi.com
For applications in related solution areas, see the following indices: Bioengineering, Computational Chemistry, DNA Sequencing, Molecular Biology, Molecular Modeling, the developer index for BIOSYM Technologies Inc and the market segment index for Chemistry, Biochem, Biotech, Materials.